Fabry's disease differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(3 intermediate revisions by one other user not shown)
Line 2: Line 2:
{{Fabry's disease}}
{{Fabry's disease}}


{{CMG}} {{AE}}
{{CMG}} {{AE}} {{GhazalS}}


==Overview==
==Overview==
Line 25: Line 25:
*[[Tortuositas vasorum]]: [[Diabetes mellitus]], [[Hypertension|arterial hypertension]], [[nephrotic syndrome]], [[neurofibromatosis type 1]], [[fibromuscular dysplasia]], [[Rendu-Osler-Weber disease]], [[Velocardiofacial syndrome]]
*[[Tortuositas vasorum]]: [[Diabetes mellitus]], [[Hypertension|arterial hypertension]], [[nephrotic syndrome]], [[neurofibromatosis type 1]], [[fibromuscular dysplasia]], [[Rendu-Osler-Weber disease]], [[Velocardiofacial syndrome]]
*[[Uveitis]]: [[Rheumatic disorders]], [[tubulointerstitial nephritis and uveitis syndrome (TINU)]], [[Bechet's disease]], [[sarcoidosis]], [[Crohn’s disease]]
*[[Uveitis]]: [[Rheumatic disorders]], [[tubulointerstitial nephritis and uveitis syndrome (TINU)]], [[Bechet's disease]], [[sarcoidosis]], [[Crohn’s disease]]
*[[Conjunctival aneurysms]]: [[Kawasaki syndrome|Kawasaki syndrom]], [[Diabetes mellitus]]
*[[Conjunctival aneurysms]]: [[Kawasaki syndrome|Kawasaki syndrome]], [[Diabetes mellitus]]


===[[Ears]]===
===[[Ears]]===
*Acute/chronic [[hearing loss]]: [[Apoplexy]], [[multiple sclerosis]], [[leopard syndrome]]
*Acute/chronic [[hearing loss]]: [[apoplexy]], [[multiple sclerosis]], [[leopard syndrome]]
*[[tinnitus]]: [[otosclerosis]], [[borreliosis]], [[sudden deafness]], [[Meniere's disease]], [[acoustic neurinoma]]
*[[tinnitus]]: [[otosclerosis]], [[borreliosis]], [[sudden deafness]], [[Meniere's disease]], [[acoustic neurinoma]]
*[[Dizziness]]: [[benign paroxysmal positional vertigo]], [[Meniere's disease]], [[vestibular neuritis]], [[cerebellar/brain stem infarction]]
*[[Dizziness]]: [[benign paroxysmal positional vertigo]], [[Meniere's disease]], [[vestibular neuritis]], [[cerebellar/brain stem infarction]]
Line 48: Line 48:
{{Reflist|2}}
{{Reflist|2}}


[[Category:Needs content]]
[[Category:Needs english review]]

Latest revision as of 10:27, 14 July 2022

Fabry's disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Fabry's disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Fabry's disease differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fabry's disease differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fabry's disease differential diagnosis

CDC on Fabry's disease differential diagnosis

Fabry's disease differential diagnosis in the news

Blogs on Fabry's disease differential diagnosis

Directions to Hospitals Treating Fabry's disease

Risk calculators and risk factors for Fabry's disease differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ghazal Sanadgol, M.D.[2]

Overview

Fabry's disease is often misdiagnosed due to its rarity and wide range of non-specific clinical manifestations. Fabry's disease be differentiated from various kind of condition based on the symptoms and organ involvement.

Differentiating Fabry's disease from other diseases

Skin manifestation

Peripheral nervous system

Gastrointestinal symptoms

Eyes

Ears

Heart

Kidneys

Central nervous system

References

  1. Stepien KM, Ciara E, Jezela-Stanek A (2020). "Fucosidosis-Clinical Manifestation, Long-Term Outcomes, and Genetic Profile-Review and Case Series". Genes (Basel). 11 (11). doi:10.3390/genes11111383. PMC 7700486 Check |pmc= value (help). PMID 33266441 Check |pmid= value (help).
  2. Zampetti A, Orteu CH, Antuzzi D, Bongiorno MR, Manco S, Gnarra M; et al. (2012). "Angiokeratoma: decision-making aid for the diagnosis of Fabry disease". Br J Dermatol. 166 (4): 712–20. doi:10.1111/j.1365-2133.2012.10742.x. PMID 22452439.
  3. Chedraoui A, Malek J, Tamraz H, Zaynoun S, Kibbi AG, Ghosn S (2010). "Acral pseudolymphomatous angiokeratoma of children in an elderly man: report of a case and review of the literature". Int J Dermatol. 49 (2): 184–8. doi:10.1111/j.1365-4632.2009.04203.x. PMID 20465644.
  4. Gorelick J, Friedman A (2020). "Diagnosis and Management of Primary Hyperhidrosis: Practical Guidance and Current Therapy Update". J Drugs Dermatol. 19 (7): 704–710. doi:10.36849/JDD.2020.5162. PMID 32726555 Check |pmid= value (help).
  5. Hoffmann B, Mayatepek E (2009). "Fabry disease-often seen, rarely diagnosed". Dtsch Arztebl Int. 106 (26): 440–7. doi:10.3238/arztebl.2009.0440. PMC 2704393. PMID 19623315.